KKAy/TaСÊó,KKAy/Ta miceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½µÌÇÌÀ,Jiangtang DecoctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ñ×Ö¢Ãô¸ÐÐÔ,inflammation sensitivityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« V3Çø,V3 regionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÂÉö²¹Æ¢ÌÀ,warm-kidney and notify-spleen decoctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏÂÇðÄÔÉñ¾­ëÄ,hypothalamic neuropeptideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« cëÄÁªºÏÒȵºËØ,c peptides combined with insulinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ת¼Òò×Ó7ÀàËÆÎï2,Transcription factor 7 like 2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ATP½áºÏºÐתÔ˵°°×A1,ATP-binding cassette transporter A1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Tangier²¡,Tangier diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȹܽáÔú,Ligation of the pancreatic ductÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô˶¯¼õ·Ê,losing weight with exerciseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿¹Ñ¹Ç¿¶ÈÖ¸Êý,Compressive Strength IndexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿àÜñÂóµ°°×ÌáÈ¡Îï,Tartarian buckwheat protein extractsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« HCVÑÇÐÍ,HCV genotypeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹Ç´úл±ê¼ÇÎï,Biochemical bone markersÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼Ò×åÐÔ¸ßÈ©¹ÌͪѪ֢¢òÐÍ,Familial hyperaldosteronism type ¢òÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÌÇÄò²¡Ö«¶Ë»µ¾Ò,Acra gangrene caused by diabetesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ÷¿ØÐ§¹û,Regulating EffectsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼×¿ºGraves²¡,Hyperthyroidism Graves diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °×ÄÚÕÏ,CataractÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¬ÉùÈ黯°×ÄÚÕÏÎü³ýÊõ,phacoemulsificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÇгýÊõ,NephrectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²£Á§ÌåÇиîÊõ,vitrectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÛ¿ô,orbitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ëÈé¸Ê¶¾ÛÌÇ¿¹Ô­,galactomannan antigenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ñÁÐßÁàº,GlipizideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Æ÷¹Ù·¢Éú,organogenesisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ñÁÐÃÀëå,glimepirideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« èã¹Ç,RadiusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°û½Çµ°°×,cytokeratinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²£Á§ÌåÇгý,VitrectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚÖ¬ËØ,VisfatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Èð¸ñÁÐÄÎ,repaglinideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÅ´«ÂÊ,HeritabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ¹¦ÄܼõÍË,HypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Çú¾úÇò,AspergillomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ת»¯ÊÔÑé,Transformation assayÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« À×ÂåÎô·Ò,RaloxifeneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹²²¡,comorbidityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºó͹³ÉÐÎÊõ,kyphoplastyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÁ°àì¢ËáÄÆ,IbandronateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÆøÎ¶,odorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼¡²¡,myopathyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÓÒ°¼ì²é·¨,perimetryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºó͹»ûÐÎ,KyphosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Ê±ûëÄ,galaninÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºËØÒÀÀµÐÍ,insulin-dependentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÅÊÆ¿¹Ô­,dominant antigenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÀÅÁ˾Ëû,EpalrestatÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ÉÈÜÐÔ°×ϸ°û½éËØ-2ÊÜÌå,sIL-2RÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾§×´Ì峬ÉùÈ黯,phacoemulsificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­ÉúÀíѧ,neurophysiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ìúµ÷ËØ,hepcidinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÀ¹ÇÖÊ,cementumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Æ¥·¥ËûÍ¡,pitavastatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ñÁÐà­Íª,gliquidoneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃÀÂúÃ¹ËØ,minocyclineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶«Áâ¿Ë˨ø,BatroxobinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ïà¹Ø±êÖ¾Îï,related markersÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ò©ÎïÒÅ´«Ñ§,pharmacogeneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÅÉäÐÔµâ,RadioiodineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ΢С°©,MicrocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃÀÎ÷ÂÉ,mexiletineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚÂð·ÈëÄ,endomorphinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »Çõ£ëåÀà,sulfonylureaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚ·ÖÃÚѧ,endocrinologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶þì¢ËáÑÎÀà,diphosphonatesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ˹·¥ËûÍ¡,simvastatinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« À×ÅÁÃ¹ËØ°Ðµ°°×,mTORÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶à°ÐµãRNAiÔª¼þ,multiple RNAi elementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºÑ×,insulitisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °ëÈéÌÇÄý¼¯ËØ-3,galectin-3Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« °¢Â×ì¢ËáÄÆ,AlendronateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¹Ä¤ºóÇ»,retroperitoneumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºËØ/ѪҺ,Insulin/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë«ì¢ËáÑÎ,bisphosphonateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ƤÖʼ¤ËØ,corticosteroidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éú³¤µ÷½ÚËØÀà,somatomedinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾§×´Ì峬ÉùÈ黯Îü³öÊõ,phacoemulsificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȸßÌÇËØ,GlucagonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ñôת,intravenous drug useÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÒÑù,cystoidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÏËά״¼¡¶¯µ°°×,F-actinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±½äåÂí¡,benzbromaroneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊæÂåµØÌØ,sulodexideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë«´×ÈðÒò,diacereinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Åà¶àÆÕÀû,perindoprilÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪС°å·´Ó¦µ°°×-1,Thrombospondin-1Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ã׸ñÁд¼,miglitolÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Âѳ²Õª³ý,ovariectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ¹¦ÄܼõµÍ,HypothyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« È«¹ú°¬×̲¡×ۺϷÀÖÎʾ·¶Çø,China Comprehensive AIDS ResponseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÐÑõ½¡Éí²Ù,aerobic exerciseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« غͪ/ѪҺ,TESTOSTERONE/bloodÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼ÙÐÔ¼××´ÅÔÏÙ¹¦ÄܼõÍËÖ¢,PseudohypoparathyroidismÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ý³éÑù,over-samplingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« LÑ¡ÔñËØ,L-selectinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹È°±õ£°·×ªÒÆÃ¸,transglutaminaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ðïÐÔ·¢×÷,seizureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«